Market Overview:
The global tumor tracking system market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in tumor tracking systems, and rising demand for minimally invasive surgeries. Based on type, the global tumor tracking system market is segmented into prostate cancer, gastric cancer, lung cancer, liver cancer, breast cancer and others. Breast Cancer held the largest share of the global tumor tracking system market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to factors such as early diagnosis of breast cancers through screening programs and rising awareness about breast cancers among women across the globe. Based on application,the global tumor tracking system market is segmented intocancer research institutes,, radiotherapy centers,, ambulatory surgical centersand others (including hospitals).
Product Definition:
A tumor tracking system is a computerized system used to track the location and status of tumors within the body. The purpose of a tumor tracking system is to ensure that all lesions within the body are accurately identified and monitored over time. This information can be used to improve treatment plans and outcomes for patients with cancer.
Prostate Cancer:
Prostate cancer is the cancer that develops in the prostate gland, which is located below the bladder. Prostate cancer generally affects men between 45 and 60 years of age. The cause of most cases of prostate cancer remains unknown; however, research has shown that factors such as overweight/obesity (body mass index over 30), diabetes (both type 1 and 2), high cholesterol levels, tobacco smoking, diet drinks consumption and a family history are associated with an increased risk for this disease.
Gastric Cancer:
Gastric cancer is a type of cancer that begins in the stomach and esophagus. Cancer occurring in the stomach may be termed as gastric or intra-gastric cancer. Intra-gastric cancers are found within the innermost layer of the stomach wall, while gastric cancers occur outside this lining (mucosa).
Application Insights:
Cancer research institutes held the largest share of over 70.0% in 2017. This is due to the rising number of cancer patients and increasing R&D activities pertaining to tumor tracking system for advanced diagnosis and treatment procedures. For instance, a research study was conducted by researchers at The University of Texas MD Anderson Cancer Center with a PET/CT imaging device that tracked lung cancer progression during treatment.
The radiotherapy centers segment is expected to grow at a lucrative rate during the forecast period owing to growing awareness about radiation safety among patients, technological advancements in equipment, and increase in availability of radiotherapy centers across countries worldwide due largely on population growth & migration patterns coupled with improved economic conditions post-recession period globally since 2009-10.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of cancer research institutes, increasing government funding for cancer research, and high healthcare expenditure in this region. For instance, according to data published by National Cancer Institute (NCI), in 2018 over 29% of all new cases were estimated to be diagnosed among men while 26% among women across the country. In addition, an estimated 1 million people are expected to die from it within the next year as stated by American Cancer Society (ACS). Thus these factors are anticipated to boost demand for tumor tracking systems during treatment procedures and drive regional growth over the forecast period.
Asia Pacific is expected witness lucrative CAGR during the forecast period owing to rising awareness about early diagnosis coupled with continuous R&D activities undertaken by key players operating in this space on a global scale.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for tumor tracking system market. According to World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from the disease worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030 due to population growth and aging. Thus, the increasing incidence of cancer is fueling the demand for tumor tracking system market globally.
- Rising awareness about benefits of tumor tracking system: There is a growing awareness among people about benefits of tumor tracking system such as early diagnosis, improved treatment outcomes, etc., which is propelling the demand for this technology globally.
- Technological advancements in tumor tracking systems: The technological advancements in tumor tracking systems are resulting in development of innovative products with better accuracy and efficiency, thereby driving the growth of this market globally . For instance , In November 2017 , Elekta introduced its newest product called Versa HD which offers high-definition images with low radiation dose . This product can be used for both brain tumors and spine tumors . Such technological advancements are helping fuel the demand for tumortracking systems globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Tumor Tracking System Market Research Report
By Type
Prostate Cancer, Gastric Cancer, Lung Cancer, Liver Cancer, Breast Cancer, Others
By Application
Cancer Research Institutes, Radiotherapy Centers, Ambulatory Surgical Centers
By Companies
Varian Medical Systems, Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc., QIAGEN, Genekam, Menarini Silicon Biosystems, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Tumor Tracking System Market Report Segments:
The global Tumor Tracking System market is segmented on the basis of:
Types
Prostate Cancer, Gastric Cancer, Lung Cancer, Liver Cancer, Breast Cancer, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Research Institutes, Radiotherapy Centers, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Varian Medical Systems
- Thermo Fisher Scientific
- Miltenyi Biotec
- Cell Biolabs, Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Genekam
- Menarini Silicon Biosystems, Inc.
Highlights of The Tumor Tracking System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prostate Cancer
- Gastric Cancer
- Lung Cancer
- Liver Cancer
- Breast Cancer
- Others
- By Application:
- Cancer Research Institutes
- Radiotherapy Centers
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tumor Tracking System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A tumor tracking system (TTS) is a medical device that uses imaging technology to track the progress of cancerous tumors. TTS can help doctors better understand the size, location, and behavior of tumors, which can help them make more informed decisions about treatment.
Some of the key players operating in the tumor tracking system market are Varian Medical Systems, Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc., QIAGEN, Genekam, Menarini Silicon Biosystems, Inc..
The tumor tracking system market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tumor Tracking System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tumor Tracking System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tumor Tracking System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tumor Tracking System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tumor Tracking System Market Size & Forecast, 2018-2028
4.5.1 Tumor Tracking System Market Size and Y-o-Y Growth
4.5.2 Tumor Tracking System Market Absolute $ Opportunity
Chapter 5 Global Tumor Tracking System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tumor Tracking System Market Size Forecast by Type
5.2.1 Prostate Cancer
5.2.2 Gastric Cancer
5.2.3 Lung Cancer
5.2.4 Liver Cancer
5.2.5 Breast Cancer
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tumor Tracking System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tumor Tracking System Market Size Forecast by Applications
6.2.1 Cancer Research Institutes
6.2.2 Radiotherapy Centers
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tumor Tracking System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tumor Tracking System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tumor Tracking System Analysis and Forecast
9.1 Introduction
9.2 North America Tumor Tracking System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tumor Tracking System Market Size Forecast by Type
9.6.1 Prostate Cancer
9.6.2 Gastric Cancer
9.6.3 Lung Cancer
9.6.4 Liver Cancer
9.6.5 Breast Cancer
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tumor Tracking System Market Size Forecast by Applications
9.10.1 Cancer Research Institutes
9.10.2 Radiotherapy Centers
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tumor Tracking System Analysis and Forecast
10.1 Introduction
10.2 Europe Tumor Tracking System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tumor Tracking System Market Size Forecast by Type
10.6.1 Prostate Cancer
10.6.2 Gastric Cancer
10.6.3 Lung Cancer
10.6.4 Liver Cancer
10.6.5 Breast Cancer
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tumor Tracking System Market Size Forecast by Applications
10.10.1 Cancer Research Institutes
10.10.2 Radiotherapy Centers
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tumor Tracking System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tumor Tracking System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tumor Tracking System Market Size Forecast by Type
11.6.1 Prostate Cancer
11.6.2 Gastric Cancer
11.6.3 Lung Cancer
11.6.4 Liver Cancer
11.6.5 Breast Cancer
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tumor Tracking System Market Size Forecast by Applications
11.10.1 Cancer Research Institutes
11.10.2 Radiotherapy Centers
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tumor Tracking System Analysis and Forecast
12.1 Introduction
12.2 Latin America Tumor Tracking System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tumor Tracking System Market Size Forecast by Type
12.6.1 Prostate Cancer
12.6.2 Gastric Cancer
12.6.3 Lung Cancer
12.6.4 Liver Cancer
12.6.5 Breast Cancer
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tumor Tracking System Market Size Forecast by Applications
12.10.1 Cancer Research Institutes
12.10.2 Radiotherapy Centers
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tumor Tracking System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tumor Tracking System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tumor Tracking System Market Size Forecast by Type
13.6.1 Prostate Cancer
13.6.2 Gastric Cancer
13.6.3 Lung Cancer
13.6.4 Liver Cancer
13.6.5 Breast Cancer
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tumor Tracking System Market Size Forecast by Applications
13.10.1 Cancer Research Institutes
13.10.2 Radiotherapy Centers
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tumor Tracking System Market: Competitive Dashboard
14.2 Global Tumor Tracking System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Varian Medical Systems
14.3.2 Thermo Fisher Scientific
14.3.3 Miltenyi Biotec
14.3.4 Cell Biolabs, Inc.
14.3.5 STEMCELL Technologies Inc.
14.3.6 QIAGEN
14.3.7 Genekam
14.3.8 Menarini Silicon Biosystems, Inc.
